Gotowa bibliografia na temat „HYPERTENSIVE DRUGS”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „HYPERTENSIVE DRUGS”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "HYPERTENSIVE DRUGS"

1

Wilson, J., M. A. Orchard, A. A. Spencer, J. A. Davies, and C. R. M. Prentice. "Anti-Hypertensive Drugs Non-Specifically Reduce “Spontaneous” Activation of Blood Platelets." Thrombosis and Haemostasis 62, no. 02 (1989): 776–80. http://dx.doi.org/10.1055/s-0038-1646901.

Pełny tekst źródła
Streszczenie:
SummaryAbnormal activation of blood platelets may be a contributory factor in the accelerated vascular disease which occurs in hypertension. We investigated the effects of lowering blood pressure in 12 patients with mild hypertension on several aspects of platelet function, initially in a placebo-controlled, double-blind, crossover study with nisoldipine, and subsequently in the same patients comparing nisoldipine with the patients’ usual anti-hypertensive therapy. Values were compared with those from an age, sex-matched control population. Seven hypertensive patients with renal failure were a
Style APA, Harvard, Vancouver, ISO itp.
2

O'Collins, Victoria E., Geoffrey A. Donnan, Malcolm R. Macleod, and David W. Howells. "Hypertension and Experimental Stroke Therapies." Journal of Cerebral Blood Flow & Metabolism 33, no. 8 (2013): 1141–47. http://dx.doi.org/10.1038/jcbfm.2013.88.

Pełny tekst źródła
Streszczenie:
Hypertension is an established target for long-term stroke prevention but procedures for management of hypertension in acute stroke are less certain. Here, we analyze basic science data to examine the impact of hypertension on candidate stroke therapies and of anti-hypertensive treatments on stroke outcome. Methods: Data were pooled from 3,288 acute ischemic stroke experiments (47,899 animals) testing the effect of therapies on infarct size (published 1978-2010). Data were combined using meta-analysis and meta-regression, partitioned on the basis of hypertension, stroke model, and therapy. Res
Style APA, Harvard, Vancouver, ISO itp.
3

Wang, Jiwu. "History of Development, Classification, Mechanism of Action and Rational Application of Major Anti-Hypertensive Drugs." International Journal of Public Health and Medical Research 1, no. 2 (2024): 44–52. http://dx.doi.org/10.62051/ijphmr.v1n2.07.

Pełny tekst źródła
Streszczenie:
With the rise of the aging population, the number of people with high blood pressure is increasing. Hypertension can cause cerebral hemorrhage, cerebral infarction, heart failure, coronary atherosclerotic heart disease and renal failure. One of the most common treatments for hypertension is drug therapy. Common anti-hypertensive drugs include angioplasty-converting enzyme inhibitors, calcium channel blockers, adrenergic receptor antagonists, diuretics, central anti-hypertensive drugs and vasodilation. The types of drugs used vary depending on the individual's condition. This article reviews th
Style APA, Harvard, Vancouver, ISO itp.
4

Bhandary, Apeksha, and Prasan R. Bhandari. "Drug usage pattern of anti-hypertensive drugs in elderly diabetic, hypertensive in-patients with or without impaired renal function in a tertiary care hospital." International Journal of Basic & Clinical Pharmacology 7, no. 4 (2018): 696. http://dx.doi.org/10.18203/2319-2003.ijbcp20181172.

Pełny tekst źródła
Streszczenie:
Background: Hypertension (HTN) and Diabetes mellitus (DM) are the leading contributors to the cardiovascular mortality and morbidity. Drug utilisation studies (DUS) are potential tools in the evaluation in health care systems. Objectives was to analyse the drug usage pattern of anti-hypertensives in elderly hypertensive diabetic in-patients in a tertiary hospital. To analyse drug usage pattern of anti-hypertensives in elderly hypertensive, diabetic in-patients with renal impairment in a tertiary hospital.Methods: The study population consisted of 165 hypertensive diabetic in-patients at Shri D
Style APA, Harvard, Vancouver, ISO itp.
5

Risna, Amalia, Jauhar Latifah, Linda Permata Sari, Ronalisa Ronalisa, Henny Maryani, and Difa Intannia. "PROFIL PERESEPAN PENGGUNAAN ANTIHIPERTENSI PADA PASIEN RAWAT JALAN DI PUSKESMAS SUNGAI ULIN PERIODE OKTOBER 2020." Jurnal Insan Farmasi Indonesia 5, no. 1 (2022): 8–15. http://dx.doi.org/10.36387/jifi.v5i1.913.

Pełny tekst źródła
Streszczenie:
Hypertension is a disease that often causes death because many people do not realize it. People have hypertension if the blood pressure above 140/90 mmHg after regular checking. In Sungai Ulin Public health center, hypertension is the second-highest disease. The study aimed to determine the characteristics of hypertensive patients and the profile of prescribing the use of anti-hypertensive drugs in outpatients in the period October 2020 at Sungai Ulin Public health center. This research is an observational descriptive study using retrospective data with the inclusion criteria. A population of
Style APA, Harvard, Vancouver, ISO itp.
6

Aryunadi, Yudha Fahmi, Ahmad Azrul Zuniarto, Fitri Zakiah, and Anggun Marselina Hermawan. "Effectiveness and Monitoring of Side Effects of Hypertension Drugs in the Elderly in Kalijaga Village." Saudi Journal of Medical and Pharmaceutical Sciences 10, no. 11 (2024): 855–62. https://doi.org/10.36348/sjmps.2024.v10i11.011.

Pełny tekst źródła
Streszczenie:
Hypertension is the disease with the highest prevalence in Indonesia. Prevalence of hypertension in the elderly aged 55-75 years and above, which is 62.63% of the overall percentage of people with hypertension. However, many elderly people are not aware and responsive to the treatment of hypertension. The use of anti-hypertensive drugs is often not taken with good procedures. The purpose of this study was to determine the effectiveness and side effects of anti-hypertensive drugs consumed by the elderly in Kalijaga. Sampling using purposive sampling technique with a sample of 30 respondents wit
Style APA, Harvard, Vancouver, ISO itp.
7

Jaryal, Ajay, Bhupender Kumar, Nripen Gaur, Kapil Sharma, Sanjay Vikrant, and Nitin Kumar. "Prevalence of hypertension-mediated target organ damage in hypertensive patients in an outpatient setting – An observational study." International Journal of Noncommunicable Diseases 10, no. 1 (2025): 12–16. https://doi.org/10.4103/jncd.jncd_51_24.

Pełny tekst źródła
Streszczenie:
ABSTRACT Aim: We aimed to study the clinical profile of hypertensive patients in an outpatient setting and to assess the burden and pattern of hypertension-mediated target organ damage (HMOD). Materials and Methods: A prospective observational study evaluated the clinical profile of hypertensive patients who attended a general internal medicine outpatient clinic over 1 year from April 2022 to March 2023. Results: A total of 454 patients (64.5% – preexisting hypertension, 35.5% – newly diagnosed) were found hypertensive during outpatient visits during the study period. About 22.7% had symptoms
Style APA, Harvard, Vancouver, ISO itp.
8

Cífková, Renata. "Antiplatelet and Lipid-lowering Drugs in Hypertension." European Cardiology Review 9, no. 1 (2014): 16. http://dx.doi.org/10.15420/ecr.2014.9.1.16.

Pełny tekst źródła
Streszczenie:
Antiplatelet therapy, and low-dose acetylsalicylic acid (ASA) in particular, is recommended in hypertensive patients with previous cardiovascular events and is considered in hypertensive patients with reduced renal function or a high cardiovascular (CV) risk, provided blood pressure is well-controlled. Acetylsalicylic acid is not recommended in low-to-moderate risk hypertensive patients in whom absolute benefit and harm are equivalent. Further trials evaluating antithrombotic therapy including newer agents in hypertension are needed. Women at high and moderate risk of pre-eclampsia are advised
Style APA, Harvard, Vancouver, ISO itp.
9

Ullah, Mohammad, Suman Kumar Saha, Md Toufiqur Rahman, Md Abdul Karim, and Rashid Ahmed. "Nonadherence to Drugs among the Hypertensive Patients in Outpatient Department of a Secondary Hospital of Bangladesh." Cardiovascular Journal 11, no. 2 (2019): 105–13. http://dx.doi.org/10.3329/cardio.v11i2.40409.

Pełny tekst źródła
Streszczenie:
Background: One fifth Bangladeshi adults are hypertensive. Forty percent of them know that they are hypertensive. 53% to 75% hypertensive people have got uncontrolled hypertension. One of the most important causes of uncontrolled hypertension is nonadherence to drugs. We tried to find the causes of non adherence of drugs among the patients with HTN in a secondary care hospital of Bangladesh.
 Methods: The study was conducted from March 2018 to June 2018. Total 144 patients with HTN were included in the study. Taking drugs in less than 80% of the days of previous six months was defined as
Style APA, Harvard, Vancouver, ISO itp.
10

Rajak, Devraj, Deepali Sahu, Anushree Jain, et al. "Review on Toxicity of Antihypertensive Drugs." Asian Journal of Dental and Health Sciences 2, no. 4 (2022): 64–68. http://dx.doi.org/10.22270/ajdhs.v2i4.28.

Pełny tekst źródła
Streszczenie:
Adverse drug reactions are common and pose a serious health problem, limiting treatment options, causing compliance issues, and even leading to therapy discontinuation. Hypertension is a chronic disease that is regarded as a major risk factor for cardiovascular disease. To achieve a target blood pressure in an individual patient, a wide range of anti-hypertensive agents are available as single or combination therapy, whereas combination therapy increases the risk of developing Adverse Drug Reaction. Hypertensive patients frequently have coexisting disease conditions such as hyperlipidemia, imp
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "HYPERTENSIVE DRUGS"

1

Nievelstein, Hubert Nicolas Maria Willem. "Hemodynamic effects of antihypertensive drugs in conscious spontaneously hypertensive rats." Maastricht : Maastricht : Rijksuniversiteit Limburg ; University Library, Maastricht University [Host], 1987. http://arno.unimaas.nl/show.cgi?fid=5367.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Beaubien, Eliot R. "Non-steroidal anti-inflammatory drugs and the risk of end stage renal disease in hypertensive individuals." Thesis, McGill University, 2004. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=81593.

Pełny tekst źródła
Streszczenie:
Objective. To examine the association between non-steroidal anti-inflammatory drug (NSAID) use and end stage renal disease (ESRD) among hypertensive subjects.<br>Study design. We conducted a nested case-control study within a cohort of 77,887 hypertensive adult subjects within the province of Saskatchewan, Canada.<br>Outcome. The primary outcome was ESRD, defined by chronic dialysis or renal transplantation.<br>Exposure. NSAID exposure was determined using prescription records, for various time windows up to 10 years preceding the onset of end stage renal disease.<br>Statistical analysi
Style APA, Harvard, Vancouver, ISO itp.
3

Komulainen, S. (Silja). "Effect of antihypertensive drugs on blood pressure during exposure to cold:experimental study in normotensive and hypertensive subjects." Doctoral thesis, University of Oulu, 2007. http://urn.fi/urn:isbn:9789514286131.

Pełny tekst źródła
Streszczenie:
Abstract The aim of the present study was to describe the effects of different types of cold exposures on blood pressure (BP) and heart rate (HR) and to test how these cold-induced effects are modulated by antihypertensive drugs representing different kind of mechanisms of action. The tested drugs represented the following antihypertensive drug subgroups: metoprolol from beta-blocking agents, carvedilol from alfa- and beta-blocking agents, lisinopril from angiotensin converting enzyme inhibitors, eprosartan from angiotensin II antagonists, amlodipine from calcium channel blockers and hydrochlo
Style APA, Harvard, Vancouver, ISO itp.
4

Filho, Gilberto Senechal de Goffredo. "Incapacidade temporária para atividades habituais: relação com a pressão arterial e o uso de terapia farmacológica antihipertensiva no Estudo Pró-Saúde." Universidade do Estado do Rio de Janeiro, 2008. http://www.bdtd.uerj.br/tde_busca/arquivo.php?codArquivo=5021.

Pełny tekst źródła
Streszczenie:
A hipertensão arterial (HA) desempenha papel determinante na ocorrência de eventos clínicos graves, havendo entretanto controvérsia quanto ao seu impacto no cotidiano do portador. A incapacidade temporária para a realização de atividades habituais, definida como uma restrição temporária na capacidade funcional habitual do indivíduo, é um indicador de saúde recomendado pela Organização Mundial da Saúde para uso em estudos populacionais. A partir do objetivo geral de investigar a associação entre hipertensão arterial e incapacidade temporária para atividades habituais, delineamos os seguintes ob
Style APA, Harvard, Vancouver, ISO itp.
5

Forino, Andrew Stephen. "Determining Effects of the PAF-R and Anti-Hypertensive Drugs Mediated Microvesicle Particle Release in Modulating Anti-Tumor Response of Lung Cancer." Wright State University / OhioLINK, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=wright1590691151424173.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Merlo, Juan. "Pharmacoepidemiologic studies on cardiovascular drugs with special reference to the effectiveness and safety of blood pressure lowering drugs /." Lund : Dept. of Community Medicine, Lund University, and the NEPI Foundation, 1998. http://books.google.com/books?id=c_BsAAAAMAAJ.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Moore, Suzanne P. "Adherence to randomised drug regimens of patients enrolled in the Second Australian National Blood Pressure Study : a description of the patterns of adherence and of factors influencing non-adherence /." [St. Lucia, Qld.], 2001. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe16251.pdf.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Yates, John. "Haemodynamic effects of vasoactive drugs in experimental portal hypertension." Thesis, Liverpool John Moores University, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.337787.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Yu, Zhen. "Altered drug responses in diabetic and hypertensive-diabetic cardiomyopathy." Thesis, University of British Columbia, 1990. http://hdl.handle.net/2429/29406.

Pełny tekst źródła
Streszczenie:
Diabetes mellitus has been associated with both clinical and experimental cardiac dysfunction. Diabetic cardiomyopathy which is characterized by depressed cardiac contractility is accompanied by a variety of biochemical changes in Ca⁺⁺ metabolism. This cardiomyopathy may occur in the presence of normal coronary arteries and normal blood pressure. However, some studies have shown that hypertension is more prevalent among diabetics and can aggravate the cardiovascular abnormalities associated with diabetes. To understand the mechanisms of diabetic cardiomyopathy and consequences of combined hype
Style APA, Harvard, Vancouver, ISO itp.
10

Greer, I. A. "The effect of anti-hypertensive agents on platelets, prostacylin and thromboxane and observations on prostacyclin and thromboxane in normal and hypertensive pregnancy." Thesis, University of Glasgow, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.380334.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "HYPERTENSIVE DRUGS"

1

Switzerland) International Symposium Clonidine in Hypertension (1984 Geneva. Low dose oral and transdermal therapy of hypertension: International Symposium Clonidine in Hypertension, Geneva, 14th-16th June, 1984. Steinkopff, 1985.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

M, Drayer Jan I., Lowenthal David T, and Weber Michael A, eds. Drug therapy in hypertension. Dekker, 1987.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

H, Messerli Franz, and Opie Lionel H, eds. Combination drug therapy for hypertension. Author's Pub. House, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Mann, Samuel J. Hypertension and you: Old drugs, new drugs, and the right drugs for your high blood pressure. Rowman & Littlefield Publishers, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

van, Zwieten P. A., and Greenlee William J, eds. Antihypertensive drugs. Harwood Academic Publishers, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

1947-, Martin John E., and Dubbert Patricia M, eds. Non-drug treatments for essential hypertension. Pergamon Press, 1988.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Bönner, Gerd. Prostacyclin and hypertension. Springer-Verlag, 1990.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Parsont, Wolfson Rita, ed. How to control high blood pressure without drugs. Scribner, 1986.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Walter, Flamenbaum, and Punzi Henry A, eds. Hypertension. Futura Pub. Co., 1989.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Richard, Trubo, ed. The H.A.R.T. program: Lower your blood pressure without drugs. HarperCollins Publishers, 1992.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "HYPERTENSIVE DRUGS"

1

Iturrioz, Xavier, Annabelle Reaux, Le Goazigo, and Catherine Llorens-Cortes. "Aminopeptidase Inhibitors as Anti-Hypertensive Drugs." In Aminopeptidases in Biology and Disease. Springer US, 2004. http://dx.doi.org/10.1007/978-1-4419-8869-0_11.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Kuriyama, Yoshihiro, Tohru Sawada, and Teruo Omae. "Antihypertensive Drugs and Cerebral Circulation." In How Should Elderly Hypertensive Patients Be Treated? Springer Japan, 1989. http://dx.doi.org/10.1007/978-4-431-68340-7_5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Cockcroft, John R., and David J. Webb. "Phase I Trials on Anti-hypertensive Drugs." In Early Phase Drug Evaluation in Man. Macmillan Education UK, 1990. http://dx.doi.org/10.1007/978-1-349-10705-6_24.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Voicu, Victor, and Maria Dorobantu. "New Drugs for the Hypertensive Failing Heart." In Updates in Hypertension and Cardiovascular Protection. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-93320-7_20.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Nakamaru, Mitsuaki, Toshio Ogihara, Hiroshi Mikami, et al. "Complications and the Choice of Antihypertensive Drugs in the Elderly." In How Should Elderly Hypertensive Patients Be Treated? Springer Japan, 1989. http://dx.doi.org/10.1007/978-4-431-68340-7_21.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Sarros, G., H. Nastou, A. Nastos, V. Sarrou, N. Fotopoulos, and J. Anastassopoulou. "Molecular Design and FT-IR Spectra of Hypertensive Drugs." In Spectroscopy of Biological Molecules. Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0371-8_261.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Kirpizidis, H. G. "Quality of Life, Drugs and Diet in Hypertensive Patients." In Handbook of Disease Burdens and Quality of Life Measures. Springer New York, 2010. http://dx.doi.org/10.1007/978-0-387-78665-0_173.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Agrawal, S. S. "Development of Transdermal and Transbuccal Drug Delivery Systems for Cardioactive Drugs with Special Reference to Anti- Hypertensive Agents." In Atherosclerosis, Hypertension and Diabetes. Springer US, 2003. http://dx.doi.org/10.1007/978-1-4419-9232-1_19.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Escher, Emanuel. "Angiotensin II Antagonists with Prolonged Duration of Action Possible Anti-Hypertensive Drugs." In Molecular Biology of Brain and Endocrine Peptidergic Systems. Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-8801-2_3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Bernstein, Donald P. "How Should You Manage Anti-Hypertensive Drugs in Morbidly Obese Surgical Patients?" In Controversies in the Anesthetic Management of the Obese Surgical Patient. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2634-6_8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "HYPERTENSIVE DRUGS"

1

Biswas, Md Emran, M. D. Fazle Hasan Mihad, Farhad Hossain Sojib, et al. "A Bioinformatics Approach to Uncover Hub Genes and Potential Drug Targets of Stroke, Heart-Disease, Hyperglycemia, and Hypertension." In 2024 27th International Conference on Computer and Information Technology (ICCIT). IEEE, 2024. https://doi.org/10.1109/iccit64611.2024.11022540.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Wilson, J., M. A. Orchard, A. A. Spencer, J. A. Davies, and C. R. M. Prentice. "TREATMENT OF RAISED BLOOD PRESSURE WITH NISOLDIPINE REDUCES "SPONTANEOUS" PLATELET AGGREGATION IN WHOLE BLOOD." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644260.

Pełny tekst źródła
Streszczenie:
Hypertensive patients are at risk of premature vascular disease, and abnormalplatelet function in hypertensive subjects may contribute to vascular damage. Ina placebo controlled, double blind, cross over study, we have investigated theeffect of treatment of moderate hypertension with nisoldipine (a 1,4, dihydropyridine calcium antagonist) on several aspects of platelet function. In 12 hypertensive subjects, venous blood samples were taken for platelet count, PCV, βTG, PF4, and aggregation to standard doses of ADP and adrenaline in whole blood. Platelet aggregation in whole blood which occurred
Style APA, Harvard, Vancouver, ISO itp.
3

Martins, A. V. V., J. G. A. L. Junior, L. A. Bortolotto, G. Lorenzi-Filho, and L. F. Drager. "Insomnia is Common in Patients with Hypertension and Associated with Higher Need of Anti-hypertensive Drugs." In XIX Congresso Brasileiro do Sono. Thieme Revinter Publicações Ltda., 2023. http://dx.doi.org/10.1055/s-0043-1770250.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Suryantara, A. A., I. Suyasa, Ni Kamaryati, and Ida Diyu. "Determinant Factors Affecting Adherence of Hypertensive Patients to Taking Antihypertensive Drugs." In The Bali Biennial International Conference on Health Sciences. SCITEPRESS - Science and Technology Publications, 2022. http://dx.doi.org/10.5220/0011940700003576.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Yalcin, Huseyin C., Mohamed A. Elrayess, Hadeel T. Al-Jighefee, Mahmoud Khatib A. A. Al-Ruweidi, Shamma Almuraikhy, and Hadi M. Yassine. "Soluble ACE2 and Angiotensin II levels Modulated in Hypertensive COVID-19 Patients treated with different Antihypertension Drugs." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0085.

Pełny tekst źródła
Streszczenie:
Hypertension is a major risk factor and common comorbidity among severe Coronavirus Disease 2019 (COVID-19) patients. Prominent antihypertensive drugs, such as angiotensin-converting-enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) can modulate the expression of angiotensin-converting enzyme 2 (ACE2) and may influence COVID-19 prognosis. Other classes of antihypertensive drugs, such as beta-blockers (BB) and calcium channel blockers (CCB) are associated with reduced mortality. Still, their effect on the circulating levels of ACE2 and angiotensin II, as well as the severity of C
Style APA, Harvard, Vancouver, ISO itp.
6

Prihayati, Apriliya, and Pujiyanto Pujiyanto. "Drug Utilization Pattern and Cost Estimates of Anti-Hypertensive Drugs in Pharmacies under the National Health Insurance Program." In The 6th International Conference on Public Health 2019. Masters Program in Public Health, Graduate School, Universitas Sebelas Maret, 2019. http://dx.doi.org/10.26911/the6thicph-fp.04.06.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Prihayati, Apriliya, and Pujiyanto Pujiyanto. "Drug Utilization Pattern and Cost Estimates of Anti-Hypertensive Drugs in Pharmacies Under the National Health Insurance Program." In The 6th International Conference on Public Health 2019. Masters Program in Public Health, Graduate School, Universitas Sebelas Maret, 2019. http://dx.doi.org/10.26911/the6thicph.04.60.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Miloradović, Vladimir, and Neda Ćićarić. "Approaches in the Treatment of Uncontrolled Hypertension." In 7th International Congress of Cardionephrology KARNEF 2025. Punta Niš, 2025. https://doi.org/10.46793/karnef25.332m.

Pełny tekst źródła
Streszczenie:
Despite the availability of antihypertensive drugs, many patients worldwide have uncontrolled hypertension (1,2). In this regard, the term „resistant hypertension“ was introduced, with a prevalence of 10%-20% in hypertensive patients (3). According to the current guidelines of the European Association of Cardiology, hypertension is defined as resistant when the treatment strategy, which includes appropriate lifestyle measures and treatment with maximum or maximally tolerated doses of diuretics (thiazides and thiazide-like diuretics), blockers of the renin-angiotension-aldosterone system (RAAS)
Style APA, Harvard, Vancouver, ISO itp.
9

Rajendran, Rasvini, and Zaitul Marlizawati Zainuddin. "The Determining Factors in Prescribing Anti-Hypertensive Drugs to First-Ever Ischemic Stroke Patients." In 2016 International Conference on Industrial Engineering, Management Science and Application (ICIMSA). IEEE, 2016. http://dx.doi.org/10.1109/icimsa.2016.7504041.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Daudt, Pedro Eugênio Deboni, Alexandre Grunfeld Starling Jardim, and Felipe Ibiapina dos Reis. "Arterial hypertension and cerebrovascular accidents. epidemiological profile of patients attended between 2013 and 2019 in Joinville, Santa Catarina, Brazil." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.344.

Pełny tekst źródła
Streszczenie:
Introduction: Cerebrovascular accident (CVA) is the second cause of death in the world, and arterial hypertension (AH) is the main risk factor. Objetives: To evaluate the prevalence of AH and the epidemiological profile of patients who suffered CVA, first and recurrent events, registered at JOINVASC, between 2013 and 2019. Methodology: An observational, descriptive, retrospective study, analyzing demographic data and risk factors, in patients that suffered CVA, first or recurrent event, was done. Results: In the study period, 6057 CVA events were registered, 4402(72.6%) patients were classifie
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "HYPERTENSIVE DRUGS"

1

Zhang, Yun. Anti-hypertensive drugs for hyperuricemia: a systematic review and network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.10.0059.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Xin, Yuning, Hongyu Li, Gungyu Cheng, et al. Evaluation of the Effectiveness and Safety of Acupuncture in the Treatment of Cervicogenic Hypertension A Protocol for Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.12.0036.

Pełny tekst źródła
Streszczenie:
Review question / Objective: The purpose of this study is to explore the efficacy and safety of acupuncture in the treatment of patients with cervicogenic hypertension,Through scientific verification, it provides clinicians with application reference and provides more choices for patients to solve pain. Patients included should have a clear diagnosis of cervicogenic hypertension(In the absence of antihypertensive drugs, blood pressure was measured 3 times a day, systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg; or a clear history of hypertension and Diagnosis of cer
Style APA, Harvard, Vancouver, ISO itp.
3

Fillipin, Federico, Pamela Seron, and Ruvistay Gutierrez-Arias. Effectiveness of antihypertensive drugs to prevent cognitive decline, mild cognitive impairment, and dementia. An overview of systematic reviews. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.12.0057.

Pełny tekst źródła
Streszczenie:
Review question / Objective: To determine effectiveness of antihypertensive drugs to prevent different dementia subtypes such as Alzheimer’s disease and vascular dementia. Condition being studied: Dementia is a global health burden, with the number of affected individuals increasing. A recent meta-analysis reported that the prevalence of all-type dementia was 697 per 10,000 people and the prevalence of Alzheimer’s disease was 324 per 10,000 people. The SHEP and SYST-EUR were the two first randomized controlled trials to show that hypertension treatment reduces dementia risk.
Style APA, Harvard, Vancouver, ISO itp.
4

Li, YueXin, YangXiao Chen, Lin Fu, et al. A Bayesian Network Meta-analysis on the Efficacy and Safety of Novel Targeted Drugs for Type Ⅰ Pulmonary Hypertension. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.12.0023.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Zhao, Jing, Yuanyuan Zeng, Jieqiong Weng, et al. Evening dosing versus morning regimen drug therapy for hypertension: a meta-analysis of randomized controlled trial. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.8.0005.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Treadwell, Jonathan R., James T. Reston, Benjamin Rouse, Joann Fontanarosa, Neha Patel, and Nikhil K. Mull. Automated-Entry Patient-Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes. Agency for Healthcare Research and Quality (AHRQ), 2021. http://dx.doi.org/10.23970/ahrqepctb38.

Pełny tekst źródła
Streszczenie:
Background. Automated-entry consumer devices that collect and transmit patient-generated health data (PGHD) are being evaluated as potential tools to aid in the management of chronic diseases. The need exists to evaluate the evidence regarding consumer PGHD technologies, particularly for devices that have not gone through Food and Drug Administration evaluation. Purpose. To summarize the research related to automated-entry consumer health technologies that provide PGHD for the prevention or management of 11 chronic diseases. Methods. The project scope was determined through discussions with Ke
Style APA, Harvard, Vancouver, ISO itp.
7

Lifestyle changes may be more important than drugs for mild hypertension. National Institute for Health Research, 2019. http://dx.doi.org/10.3310/signal-000713.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Introducing magnesium sulphate for the management of pregnancy induced hypertension. Population Council, 2005. http://dx.doi.org/10.31899/rh16.1012.

Pełny tekst źródła
Streszczenie:
Global studies have demonstrated that using magnesium sulphate (MgSO4) to manage hypertensive disease in pregnancy reduces morbidity and mortality due to severe pre-eclampsia/eclampsia, one of the five direct causes of maternal death. Many countries have been slow to introduce MgSO4 to the detriment of women’s health. There are also critical gaps in health-care provider knowledge, skills, and practice in management of eclampsia. Although the use of MgSO4 was introduced successfully to the Maternity Unit at Kenyatta National Hospital, Nairobi, in 2001, there has been no systematic introduction
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!